BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 15560776)

  • 1. Models and mechanisms of O-O bond activation by cytochrome P450. A critical assessment of the potential role of multiple active intermediates in oxidative catalysis.
    Hlavica P
    Eur J Biochem; 2004 Nov; 271(22):4335-60. PubMed ID: 15560776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proton-shuttle mechanism mediated by the porphyrin in benzene hydroxylation by cytochrome p450 enzymes.
    de Visser SP; Shaik S
    J Am Chem Soc; 2003 Jun; 125(24):7413-24. PubMed ID: 12797816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gauging the relative oxidative powers of compound I, ferric-hydroperoxide, and the ferric-hydrogen peroxide species of cytochrome P450 toward C-H hydroxylation of a radical clock substrate.
    Derat E; Kumar D; Hirao H; Shaik S
    J Am Chem Soc; 2006 Jan; 128(2):473-84. PubMed ID: 16402834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the ruthenium analogue of compound I of cytochrome p450 an efficient oxidant? A theoretical investigation of the methane hydroxylation reaction.
    Sharma PK; De Visser SP; Ogliaro F; Shaik S
    J Am Chem Soc; 2003 Feb; 125(8):2291-300. PubMed ID: 12590559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propene activation by the oxo-iron active species of taurine/alpha-ketoglutarate dioxygenase (TauD) enzyme. How does the catalysis compare to heme-enzymes?
    de Visser SP
    J Am Chem Soc; 2006 Aug; 128(30):9813-24. PubMed ID: 16866538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A theoretical study on the mechanism of camphor hydroxylation by compound I of cytochrome p450.
    Kamachi T; Yoshizawa K
    J Am Chem Soc; 2003 Apr; 125(15):4652-61. PubMed ID: 12683838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxo-iron and oxenoid-iron species as alternative oxygenating agents in cytochrome P450-catalyzed reactions: switching by threonine-302 to alanine mutagenesis of cytochrome P450 2B4.
    Vaz AD; Pernecky SJ; Raner GM; Coon MJ
    Proc Natl Acad Sci U S A; 1996 May; 93(10):4644-8. PubMed ID: 8643457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroperoxoferric heme intermediate as a second electrophilic oxidant in cytochrome P450-catalyzed reactions.
    Jin S; Bryson TA; Dawson JH
    J Biol Inorg Chem; 2004 Sep; 9(6):644-53. PubMed ID: 15365901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic insights on the ortho-hydroxylation of aromatic compounds by non-heme iron complex: a computational case study on the comparative oxidative ability of ferric-hydroperoxo and high-valent Fe(IV)═O and Fe(V)═O intermediates.
    Ansari A; Kaushik A; Rajaraman G
    J Am Chem Soc; 2013 Mar; 135(11):4235-49. PubMed ID: 23373840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of perferryl-oxo oxidant in alkane hydroxylation catalyzed by cytochrome P450: a hybrid density functional study.
    Isobe H; Yamaguchi K; Okumura M; Shimada J
    J Phys Chem B; 2012 Apr; 116(16):4713-30. PubMed ID: 22510212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfoxidation mechanisms catalyzed by cytochrome P450 and horseradish peroxidase models: spin selection induced by the ligand.
    Kumar D; de Visser SP; Sharma PK; Hirao H; Shaik S
    Biochemistry; 2005 Jun; 44(22):8148-58. PubMed ID: 15924434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple mechanisms and multiple oxidants in P450-catalyzed hydroxylations.
    Newcomb M; Hollenberg PF; Coon MJ
    Arch Biochem Biophys; 2003 Jan; 409(1):72-9. PubMed ID: 12464246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The "somersault" mechanism for the p-450 hydroxylation of hydrocarbons. The intervention of transient inverted metastable hydroperoxides.
    Bach RD; Dmitrenko O
    J Am Chem Soc; 2006 Feb; 128(5):1474-88. PubMed ID: 16448118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How does product isotope effect prove the operation of a two-state "rebound" mechanism in C-H hydroxylation by cytochrome P450?
    Kumar D; de Visser SP; Shaik S
    J Am Chem Soc; 2003 Oct; 125(43):13024-5. PubMed ID: 14570465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient inverted metastable iron hydroperoxides in fenton chemistry. A nonenzymatic model for cytochrome p450 hydroxylation.
    Bach RD; Dmitrenko O
    J Org Chem; 2010 Jun; 75(11):3705-14. PubMed ID: 20429613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple activated oxygen species in P450 catalysis: contributions To specificity in drug metabolism.
    Coon MJ; Vaz AD; McGinnity DF; Peng HM
    Drug Metab Dispos; 1998 Dec; 26(12):1190-3. PubMed ID: 9860926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The valence bond way: reactivity patterns of cytochrome P450 enzymes and synthetic analogs.
    Shaik S; Lai W; Chen H; Wang Y
    Acc Chem Res; 2010 Aug; 43(8):1154-65. PubMed ID: 20527755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How does the axial ligand of cytochrome P450 biomimetics influence the regioselectivity of aliphatic versus aromatic hydroxylation?
    de Visser SP; Tahsini L; Nam W
    Chemistry; 2009; 15(22):5577-87. PubMed ID: 19347895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What factors influence the ratio of C-H hydroxylation versus C=C epoxidation by a nonheme cytochrome P450 biomimetic?
    de Visser SP
    J Am Chem Soc; 2006 Dec; 128(49):15809-18. PubMed ID: 17147391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-valent iron in chemical and biological oxidations.
    Groves JT
    J Inorg Biochem; 2006 Apr; 100(4):434-47. PubMed ID: 16516297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.